Your browser doesn't support javascript.
loading
Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells.
Kim, Hee-Jun; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Lee, Kyung Hun; Lau, Alan; Lee, Miso; Kim, Seongyeong; Yang, Yaewon; Kim, Jungeun; Kim, Tae Yong; Oh, Do-Youn; Brown, Jeffrey; O'Connor, Mark J; Bang, Yung-Jue.
Afiliación
  • Kim HJ; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Min A; Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Im SA; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Jang H; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Lee KH; Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Lau A; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Lee M; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Kim S; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Yang Y; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Kim J; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Kim TY; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Oh DY; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Brown J; AstraZeneca UK Ltd, Macclesfield, Cheshire, United Kingdom.
  • O'Connor MJ; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Bang YJ; Cancer Research Institute, Seoul National University, Seoul, Korea.
Int J Cancer ; 140(1): 109-119, 2017 Jan 01.
Article en En | MEDLINE | ID: mdl-27501113
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Sulfóxidos / Neoplasias de la Mama / Receptor ErbB-2 / Inhibidores de Proteínas Quinasas / Puntos de Control del Ciclo Celular Límite: Female / Humans Idioma: En Revista: Int J Cancer Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Sulfóxidos / Neoplasias de la Mama / Receptor ErbB-2 / Inhibidores de Proteínas Quinasas / Puntos de Control del Ciclo Celular Límite: Female / Humans Idioma: En Revista: Int J Cancer Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos